Jennison Associates
ARNA

Jennison Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Jennison Associates’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-33,995
Closed -$1.43M – 719
2020
Q1 		$1.43M Buy
33,995
+14,965
+79% +$686K ﹤0.01% 462
2019
Q4 		$864K Buy
19,030
+1,203
+7% +$56.9K ﹤0.01% 537
2019
Q3 		$816K Buy
+17,827
New +$1M ﹤0.01% 563

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates's ARNA Position: Q2 2020 in Review

Jennison Associates sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 33,995 shares — an estimated $1.43M sold.

Jennison Associates first reported a position in ARNA in Q3 2019 and held it in 3 quarters. The position peaked at $1.43M in Q1 2020. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Jennison Associates reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Jennison Associates sold 33,995 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $1.43M.
  • Jennison Associates first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 3 quarters.
  • Jennison Associates's Arena Pharmaceuticals Inc position peaked at $1.43M in Q1 2020.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Jennison Associates's 13F filing for Q2 2020, filed 6 Aug 2020.